Cerebrolysin (60 mg Vial) Dosage Protocol
Cerebrolysin is a porcine-brain-derived peptide mixture studied for stroke recovery, dementia, and traumatic brain injury. Clinical use spans Eastern Europe and parts of Asia.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Route: Subcutaneous (or IM) | Frequency: Once or twice daily | Half-life: Mixed
Standard Approach (3 mL = 20.00 mg/mL)
Reconstituting with 3 mL bacteriostatic water produces a concentration of 20.00 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.
| Phase / Protocol | Dose | U-100 Units | Volume | Doses per vial |
|---|---|---|---|---|
| Week 1 (titration) | 20 mg | 100 units | 1.00 mL | 3 doses |
| Week 2 | 24 mg | 120 units | 1.20 mL | 2 doses |
| Week 3 | 28 mg | 140 units | 1.40 mL | 2 doses |
| Week 4+ (target) | 32 mg | 160 units | 1.60 mL | 1 doses |
Reconstitution Steps
- Wipe the vial stopper and BAC water vial with alcohol; let dry.
- Draw 3 mL of bacteriostatic water into a sterile syringe.
- Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
- Gently swirl until fully dissolved. Do not shake.
- Label with reconstitution date. Refrigerate at 2–8°C; use within 7 days.
Supplies Needed
Estimates for an 8-week and 12-week cycle at 28 mg per dose, once or twice daily (14 doses/week).
| Item | 8-Week Cycle | 12-Week Cycle |
|---|---|---|
| Cerebrolysin (60 mg) vials | 56 vials | 84 vials |
| Insulin syringes (U-100) | 112 | 168 |
| Bacteriostatic water (10 mL) | 17 × 10 mL | 26 × 10 mL |
| Alcohol swabs | 1 × 100-pack | 2 × 100-pack |
Protocol Overview
Cerebrolysin protocols are typically run as 10–20 day intensive courses 1–2× per year, rather than continuous use. The liquid presentation is administered IM (most common) or slow IV (clinical settings).
Effects on cognition and recovery accumulate over the course; results typically appear by day 7–10 of the cycle.
Dosing Protocol
Cycle-based dosing:
- Standard (5 mL daily IM): 10–20 day course, 1–2× per year. Standard cognitive/recovery dose.
- Higher (10 mL slow IV): Stroke / acute neuro protocols, clinical setting required.
Cycle structure: 10–20 day intensive courses, 4–6 month breaks between cycles.
IV warning: Slow IV (over 15+ minutes) only — rapid administration can cause hypotension.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 7 days, protect from light |
Important Notes
How This Works
Cerebrolysin is a complex peptide mixture (free amino acids + low-molecular-weight neuropeptide fragments ~85% under 10 kDa) prepared from purified pig brain protein. Mechanisms include BDNF and NGF mimicry, antioxidant effects, modulation of inflammatory cytokines, and protection against excitotoxicity.
Potential Benefits & Side Effects
Potential Benefits
- Studied in ischemic stroke recovery — improved functional outcomes.
- Used in dementia (Alzheimer’s, vascular) protocols.
- TBI recovery — multiple Eastern European clinical studies.
- Neuroprotective in multiple animal models.
Side Effect Profile
- Generally well-tolerated.
- Injection-site reactions.
- Rare hypersensitivity reactions.
- Headache occasionally.
Lifestyle Factors
- Liquid presentation — no reconstitution needed.
- IV must be administered slowly (over 15+ min) to avoid hypotension.
- Cycled protocols (3-week on, 1-week off) common.
Injection Technique
- Intramuscular (deltoid or gluteal) or slow IV.
- IV requires medical setting — slow infusion only.